The doctoral Programme RESPImmun focuses on lung diseases and immunomodulatory mechanisms, both are highly relevant for medical research and patient care. Respiratory diseases affect over several hundred million people and rank second only to cardiovascular diseases in terms of mortality, incidence, prevalence, and socio-economic burden. RESPImmun is a thematically most stringent, top quality research program that will take PhD education to the highest level. One unique feature of this framework is its translational and interdisciplinary nature, which allows specialists from diverse fields: pulmonology, pathology, immunology, pharmacology, translational sciences, molecular biology and bioinformatics to bring their knowledge and concepts together to find the connection between chronic lung diseases, thus fostering the understanding of underlying pathologies.